Viewing nowEmpamax Tablet 25 mg (Empagliflozin L-Proline)
Empagliflozin L-Proline 31.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 202107168 · Approved 2021.10.27 · Insurance code 643309710
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in adults with type 2 diabetes. It can be used alone or in combination with other medications to enhance blood sugar control effects. Particularly in cases of type 2 diabetes patients who are not well controlled and have cardiovascular diseases, use should refer to expert guidelines. This medication improves blood sugar control and aids in diabetes management.
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with a glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but whose glomerular filtration rate remains below 60 ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered. As clinical experience in older adults aged 85 years and over is limited, initiation of treatment with this medicine is not recommended (see Precautions, 4. General Precautions).
This medication should not be administered to patients who have an allergic reaction to the active ingredient or components. It is considered unsafe for use in patients with type 1 diabetes or diabetic ketoacidosis. This medication should not be given to patients with severely impaired kidney function, specifically those with a glomerular filtration rate below 30 mL/min/1.73m2 or patients with end-stage renal disease, or those undergoing dialysis. In patients with mildly impaired kidney function, this medication should be used cautiously, and dosage adjustment or discontinuation may be necessary based on kidney function levels. In patients with mild to moderate heart failure, caution is advised, and it is not recommended for patients with severe heart failure. When used in conjunction with blood glucose-lowering agents such as insulin or sulfonylureas, the risk of hypoglycemia may necessitate a reduction in the dosage of these medications. Caution should be exercised for potential side effects such as hypoglycemia, infections, particularly genital and urinary tract infections, urinary abnormalities, dehydration symptoms, alterations in blood tests, etc. Serious metabolic anomalies such as ketoacidosis may rarely occur, so if symptoms like nausea, vomiting, abdominal pain, or shortness of breath appear, immediate consultation with healthcare providers is necessary. Elderly patients may have a higher incidence of side effects related to fluid loss, so caution is particularly important. This medication may affect the body's hydration status, so in situations of dehydration risk, blood pressure and fluid status should be closely monitored before and after administration. Additionally, this medication can rarely cause serious infections such as perineal necrosis, so if there is pain, swelling, or fever in that area, immediate notification to the healthcare provider is advised. It is recommended that women who are pregnant or planning to become pregnant do not use this medication, and breastfeeding should be discontinued if nursing. Children below 18 years of age should not use this medication as safety and efficacy have not been established. No specific toxic reactions have been reported in cases of overdose, but appropriate treatment may be necessary depending on the clinical condition. This medication may interact with other drugs, so if taking any other medications, inform your healthcare provider, especially with diuretics or insulin where caution is needed. Exercise caution when driving or operating machinery due to the risk of hypoglycemia.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature.
Light yellow, double convex, oval film-coated tablet
30 tablets/box [10 tablets/ptp x 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.